90% of patients respond to new blood cancer treatment in trial
90% of patients respond to new blood cancer treatment in trial
www.freethink.com 90% of patients respond to new blood cancer treatment in trial
Israeli researchers have developed a new form of CAR-T therapy effective against multiple myeloma, a plasma cell cancer.
![90% of patients respond to new blood cancer treatment in trial](https://lemmy.ml/pictrs/image/4c8b9c1f-c375-43b3-8754-ba2cd224435b.jpeg?format=webp&thumbnail=256)
0
comments